Daniel E. Keyler
Impact in
- Toxicology top 1%
- Virology top 5%
Papers in
-
- Nicotinic Acetylcholine Receptors Study 25
- Ion channel regulation and function 10
- Receptor Mechanisms and Signaling 8
- Genetics 25
- Venomous Animal Envenomation and Studies 25
- Co-authors
- Paul R. Pentel (42 shared papers)Mark LeSage (17 shared papers)Yoko Hieda (7 shared papers)P.R. Pentel (4 shared papers)Samuel A. Roiko (5 shared papers)Scott A. Weinstein (8 shared papers)Danielle Burroughs (3 shared papers)Susan M. Pond (7 shared papers)
- Journals
- Toxicon (10 papers)Journal of Pharmacology and Experimental Therapeutics (7 papers)Biochemical Pharmacology (6 papers)Drug Metabolism and Disposition (3 papers)International Immunopharmacology (3 papers)
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
Daniel E. Keyler
84 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 112
- Toxicology 152
- Virology 161
- Emergency Medicine 187
- Biological Psychiatry 42
- Cellular and Molecular Neuroscience 331
Countries citing papers authored by Daniel E. Keyler
This map shows the geographic impact of Daniel E. Keyler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel E. Keyler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel E. Keyler more than expected).
Fields of papers citing papers by Daniel E. Keyler
This network shows the impact of papers produced by Daniel E. Keyler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel E. Keyler. The network helps show where Daniel E. Keyler may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel E. Keyler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 85 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 82 | |
| 2 | 2000 | 82 | |
| 3 | 1997 | 77 | |
| 4 | 2003 | 70 | |
| 5 | 2013 | 65 | |
| 6 | 2018 | 64 | |
| 7 | 2005 | 63 | |
| 8 | 2005 | 62 | |
| 9 | 1999 | 56 | |
| 10 | 2008 | 56 | |
| 11 | 2004 | 55 | |
| 12 | 2011 | 55 | |
| 13 | 2007 | 54 | |
| 14 | 2004 | 52 | |
| 15 | 2003 | 46 | |
| 16 | 2006 | 46 | |
| 17 | 2013 | 44 | |
| 18 | 2010 | 43 | |
| 19 | 1992 | 37 | |
| 20 | Pattern of illicit drug use in patients referred to addiction treatment centres in Birjand, Eastern Iran. | 2013 | 34 |
About Daniel E. Keyler
Daniel E. Keyler is a scholar working on Molecular Biology, Genetics, Physiology, Virology and Epidemiology, having authored 85 papers that have together received 2.0k indexed citations. Recurring topics across this work include Venomous Animal Envenomation and Studies (25 papers), Nicotinic Acetylcholine Receptors Study (25 papers), Rabies epidemiology and control (16 papers), Smoking Behavior and Cessation (14 papers), Influenza Virus Research Studies (11 papers), Ion channel regulation and function (10 papers), Cardiac electrophysiology and arrhythmias (9 papers) and Receptor Mechanisms and Signaling (8 papers). The work is most often cited by research in Toxicology (152 citations), Virology (161 citations), Emergency Medicine (187 citations), Biological Psychiatry (42 citations) and Cellular and Molecular Neuroscience (331 citations). Daniel E. Keyler has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Paul R. Pentel, Mark LeSage, Yoko Hieda, P.R. Pentel, Samuel A. Roiko, Scott A. Weinstein, Danielle Burroughs, Susan M. Pond, Ashok K. Singh and Sofiane Ennifar. Their work appears in journals such as Toxicon, Journal of Pharmacology and Experimental Therapeutics, Biochemical Pharmacology, Drug Metabolism and Disposition and International Immunopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.